眼科和验光患者的角膜敏感性测试程序
August 2nd, 2024
角膜敏感性测试可以深入了解角膜神经的健康状况，并有助于诊断眼表疾病。我们提出了一个简洁的方案来定性评估角膜敏感性，该方案可供眼保健提供者在临床环境中轻松使用。
尽管有证据表明在各种眼部疾病中角膜敏感性发生变化，但已发表的关于角膜敏感性测试和解释的指南有限。这项研究建立了一种角膜敏感性测试方案，该方案简单、经济高效且易于由眼保健提供者在临床环境中实施。眼痛和干眼症可能由多种因素引起，包括神经功能异常。
基于精准的医学需要诊断测试，如角膜敏感性，以确定影响因素。该测试可以检测到感觉减退，这表明神经营养性角膜炎，或感觉增加，这表明神经性伤害性疼痛是导致症状的原因。由于成本和保持无菌性的挑战，角膜敏感性测试的定量方法（例如使用触觉计）在临床实践中不常使用。
虽然像我们这样的定性方法提供了一种廉价且可访问的替代方案，但对其实施和解释的指导不足。我们的方案成本低、容易获得，并且几乎不需要培训和时间，这意味着它可以由眼保健提供者在各种临床环境中执行。根据我们的经验，结果是一致的，并且该程序可以很容易地整合到现有的工作流程中以支持临床诊断。
这将有助于为进一步的研究和进一步的临床研究铺平道路，以继续提高角膜敏感性测试在我们患者中的重要性。对角膜敏感性的兴趣和研究越多，只会增强我们对这项关键测试对患者重要性的理解。
概述
角膜敏感性测试对于评估角膜神经健康和诊断眼表疾病至关重要。本文介绍了一个简单、经济实惠的定性角膜敏感性评估方案，眼科医护人员可以轻松实施。
关键研究组成部分
科学领域
- 眼科学
- 神经科学
- 临床诊断
背景
- 在各种眼部疾病中观察到角膜敏感性的改变。
- 角膜敏感性测试和解释方面的指导有限。
- 诊断测试对精准医疗至关重要。
- 定性方法为定量测试提供了一种可及的替代方案。
研究目的
- 建立一个简单的角膜敏感性测试方案。
- 促进该测试在临床环境中的实施。
- 增强对角膜敏感性在眼部健康中作用的理解。
使用的方法
- 患者舒适地定位并指示取下隐形眼镜。
- 使用无菌棉签或未上蜡的牙线作为刺激物。
- 患者报告与角膜接触时的感觉。
- 根据患者对刺激的反应进行评分。
主要结果
- 该方案低成本并且需要最少的培训。
- 结果一致并且可以轻松集成到临床工作流程中。
- 测试可以识别神经营养性角膜炎和神经病理性疼痛的贡献因素。
- 鼓励对角膜敏感性测试进行进一步研究。
结论
- 所介绍的方案增强了眼表疾病的诊断能力。
- 它支持对角膜敏感性进行更多研究的必要性。
- 对角膜敏感性的改善理解可以使患者护理受益。
常见问题
Executive Industry Relevance
Corneal sensitivity testing provides a rapid, accessible means to assess corneal nerve function, supporting early identification of neuropathic and neurotrophic changes in ocular surface disease. Integrating this qualitative assessment into ophthalmic workflows enhances diagnostic precision and informs mechanistic de-risking at the interface of neurosensory and surface pathology. Its low-cost, reproducible protocol enables broad adoption across discovery and translational research settings, supporting portfolio-wide consistency in phenotypic screening and target validation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of corneal nerve function as a mechanistic contributor to ocular surface disease phenotypes.
- Supports biological de-risking by distinguishing neuropathic from neurotrophic mechanisms in patient-derived samples.
- Facilitates predictive confidence in target selection for neurosensory and ocular surface drug programs.
Screening & Assay Development
- Prepares validated, reproducible qualitative readouts for downstream screening of candidate therapeutics affecting corneal innervation.
- Standardizes assessment of corneal sensitivity across clinical and preclinical models, supporting assay reproducibility.
- Enables rapid, scalable evaluation of intervention effects on corneal nerve function.
Translational & Preclinical Research
- Aligns phenotypic outputs with disease-relevant endpoints for translational biomarker development in ocular surface disorders.
- Supports continuity from early discovery through preclinical validation by providing a consistent, interpretable readout of nerve health.
- De-risks advancement decisions by clarifying mechanistic underpinnings of ocular pain and surface disease models.
Pipeline & Workflow Integration
This qualitative corneal sensitivity protocol fits at the intersection of early discovery, phenotypic screening, and translational research for ocular surface and neurosensory programs.
- Discovery Biology: Supports hypothesis testing on nerve function and its role in ocular surface pathology.
- Screening: Provides a reproducible, rapid assay for evaluating intervention impact on corneal sensitivity.
- Analytics: Delivers standardized, semi-quantitative scores enabling cross-condition and cross-cohort comparisons.
- Translational Research: Bridges clinical and preclinical studies by aligning outputs with disease-relevant nerve function endpoints.
- Enterprise Reuse: Offers a low-cost, scalable protocol adaptable across diverse research and clinical settings.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in mechanistic hypotheses and target validation for ocular surface disease.
- Operational Value: Enables standardized, reproducible, and rapid assessment with minimal training and infrastructure.
- Strategic Value: Improves go/no-go decisions and reduces late-stage risk by clarifying neurosensory contributions to disease.
- Portfolio Impact: Supports risk-adjusted prioritization and cross-program comparability in ocular and neurosensory pipelines.
Implementation Considerations
- Requires basic clinical expertise in ophthalmic examination and patient instruction.
- Needs only simple, sterile materials such as cotton swabs or dental floss for stimulus delivery.
- Demands consistent scoring and procedural standardization across operators and sites.
- Adaptable to both clinical and preclinical model systems with minimal protocol modification.
- Limited to qualitative assessment; quantitative sensitivity thresholds require additional instrumentation.
